Gene · 5452
Papers3,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Misdiagnosis analysis of 2291 cases of haematolymphoid neoplasms. | Front Oncol | 2023 | 37182167 | PubTator, text mining | PubMed |
| Structure and Functions of HMGB2 Protein. | Int J Mol Sci | 2023 | 37176041 | PubTator, text mining | PubMed |
Development of an In Vitro Blood Vessel Model Using Autologous Endothelial Cells Generated from Footprint-Free hiPSCs to Analyze Interactions of the Endothelium with Blood Cell Components and Vascular Implants. | Cells | 2023 | 37174617 | PubTator, text mining | PubMed |
| How I Diagnose Rosai-Dorfman Disease. | Am J Clin Pathol | 2023 | 37167084 | PubTator, text mining | PubMed |
| Quaternary Ammonium Compounds: A Chemical Class of Emerging Concern. | Environ Sci Technol | 2023 | 37157132 | PubTator, text mining | PubMed |
| Multimodal spatiotemporal phenotyping of human retinal organoid development. | Nat Biotechnol | 2023 | 37156914 | PubTator, text mining | PubMed |
| Internal Jugular Venous Thrombosis With Superior Vena Cava Syndrome: A Rare First Presentation of Gray Zone Lymphoma. | Cureus | 2023 | 37153303 | PubTator, text mining | PubMed |
| Exploring the inhibitory potential of novel piperidine-derivatives against main protease (Mpro) of SARS-CoV-2: A hybrid approach consisting of molecular docking, MD simulations and MMPBSA analysis. | J Mol Liq | 2023 | 37151376 | PubTator, text mining | PubMed |
| Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach. | In Silico Pharmacol | 2023 | 37131867 | PubTator, text mining | PubMed |
| Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD. | JCI Insight | 2023 | 37129971 | PubTator, text mining | PubMed |
| Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid. | Front Pharmacol | 2023 | 37124197 | PubTator, text mining | PubMed |
| ALK-positive histiocytosis involving the cavernous sinus: A deceptive radiologic mimic of meningioma. | Radiol Case Rep | 2023 | 37123042 | PubTator, text mining | PubMed |
| Carcinoma with signet ring cell differentiation associated with invasive breast cancer: A case report. | Oncol Lett | 2023 | 37123029 | PubTator, text mining | PubMed |
| A Rare Case of Metachronous Peripheral T-cell Non-Hodgkin Lymphoma Following Epstein-barr Virus-positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified. | Oman Med J | 2023 | 37122420 | PubTator, text mining | PubMed |
| Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway. | Chin Med J (Engl) | 2023 | 37114652 | PubTator, text mining | PubMed |
| Coexisting Nodular Sclerosis Hodgkin Lymphoma and Kimura's Disease: A Case Report and Literature Review. | Int J Mol Sci | 2023 | 37108825 | PubTator, text mining | PubMed |
| Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis. | Int J Mol Sci | 2023 | 37108242 | PubTator, text mining | PubMed |
| Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers. | Biomark Res | 2023 | 37101220 | PubTator, text mining | PubMed |
| Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity? | Diagn Pathol | 2023 | 37098615 | PubTator, text mining | PubMed |
| Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars. | Cell Genom | 2023 | 37082139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5452/papers?page=20